Skip to main content
Kamada Ltd. logo

Kamada Ltd. — Investor Relations & Filings

Ticker · KMDA ISIN · IL0010941198 TA Manufacturing
Open in API
Filings indexed 822 across all filing types
Latest filing 2015-05-12 Report Publication Anno…
Country IL Israel
Listing TA KMDA

About Kamada Ltd.

https://www.kamada.com

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Recent filings

Filing Released Lang Actions
Report of Periodic or Interim Report
Report Publication Announcement Classification · 1% confidence The document is a regulatory filing notification from KAMADA LTD, referencing the 'Report of Periodic or Interim Report' under Israeli regulations. Crucially, it states: 'Attached hereto is a report on *CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2015*'. Since the document itself is short (1614 chars) and serves primarily to announce the availability of the actual financial statements (which are attached/linked), it fits the definition of a Report Publication Announcement (RPA) rather than the comprehensive Interim Report (IR) itself. The date March 31, 2015, indicates a period shorter than a full year, consistent with an interim report being announced.
2015-05-12 English
Immediate Report
Regulatory Filings
2015-05-12 Hebrew (modern)
Immediate Report
Earnings Release Classification · 1% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority and the Tel Aviv Stock Exchange. The key sentence is: 'Attached hereto is a report on *Kamada Reports First Quarter of 2015 Financial Results*'. This indicates the document itself is an announcement about the release of financial results for the first quarter (an interim period). Since the document is short (1608 chars) and primarily serves to announce the availability of the actual results report (referenced by the PDF filename), it fits the definition of a Report Publication Announcement (RPA). If the text contained the full financial details, it would be classified as an Interim Report (IR), but here it is merely announcing the publication. Q1 2015
2015-05-12 English
Other Report or Announcement
Regulatory Filings
2015-04-28 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 1% confidence The document is very short (1594 characters) and explicitly states that an attached report is being disclosed. The key phrase is: "Attached hereto is a report on *Disclosure for debenture holders as of December 31, 2014*" followed by a filename (*April_2015_isa.pdf*). This structure—announcing the publication of an attached or linked report rather than containing the full report content—fits the definition of a Report Publication Announcement (RPA). It is not the full financial report (10-K or IR) nor a general regulatory filing (RNS), as it specifically announces the publication of a document.
2015-04-28 English
Report of Periodic or Interim Report
Regulatory Filings
2015-04-28 Hebrew (modern)

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.